DE68912419D1 - Verwendung von Uridin zur Behandlung nervöser Störungen. - Google Patents
Verwendung von Uridin zur Behandlung nervöser Störungen.Info
- Publication number
- DE68912419D1 DE68912419D1 DE89830264T DE68912419T DE68912419D1 DE 68912419 D1 DE68912419 D1 DE 68912419D1 DE 89830264 T DE89830264 T DE 89830264T DE 68912419 T DE68912419 T DE 68912419T DE 68912419 D1 DE68912419 D1 DE 68912419D1
- Authority
- DE
- Germany
- Prior art keywords
- uridine
- nervous disorders
- treat nervous
- treat
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT48118/88A IT1219667B (it) | 1988-06-21 | 1988-06-21 | Impiego di uridina nel trattamento farmacologico di disturbi dovuti ad alterato equilibrio dopaminergico |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68912419D1 true DE68912419D1 (de) | 1994-03-03 |
DE68912419T2 DE68912419T2 (de) | 1994-08-04 |
Family
ID=11264638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68912419T Expired - Fee Related DE68912419T2 (de) | 1988-06-21 | 1989-06-14 | Verwendung von Uridin zur Behandlung nervöser Störungen. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4960759A (de) |
EP (1) | EP0348360B1 (de) |
JP (1) | JPH0623109B2 (de) |
KR (1) | KR900000092A (de) |
AT (1) | ATE100322T1 (de) |
CA (1) | CA1327003C (de) |
DE (1) | DE68912419T2 (de) |
IT (1) | IT1219667B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2634374B1 (fr) * | 1988-07-19 | 1993-10-15 | Laboratoires Serobiologiques | Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi |
WO1994026280A1 (en) * | 1993-05-19 | 1994-11-24 | Korea Green Cross Corporation | Remedy for arthritis containing uridine as active ingredient |
IT1290781B1 (it) * | 1996-05-28 | 1998-12-10 | Polifarma Spa | Agente attivo terapeutico per il trattamento di malattie degenerative neuronali. |
US5962459A (en) * | 1996-05-28 | 1999-10-05 | Polifarma S.P.A. | Therapeutic active agent for treatment of neuron degenerative diseases |
US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
US20070004670A1 (en) * | 1998-07-31 | 2007-01-04 | Richard Wurtman | Compositions containing citicoline, and methods of use thereof |
US8314064B2 (en) | 1998-07-31 | 2012-11-20 | Massachusetts Institute Of Technology | Uridine administration stimulates membrane production |
US8518882B2 (en) | 1998-07-31 | 2013-08-27 | Massachusetts Institute Of Technology | Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same |
US20050203053A1 (en) * | 1999-07-30 | 2005-09-15 | Wurtman Richard J. | Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function |
DE69941586D1 (de) | 1998-07-31 | 2009-12-03 | Massachusetts Inst Technology | Verwendung von Uridin in Kombination mit Cholin zur Behandlung von Gedächtnisstörungen |
US20060069061A1 (en) * | 1998-07-31 | 2006-03-30 | Dick Wurtman | Compositions containing uridine and choline, and methods utilizing same |
US8143234B2 (en) | 1998-07-31 | 2012-03-27 | Massachusetts Institute Of Technology | Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function |
US7915233B1 (en) | 1998-08-31 | 2011-03-29 | Wellstat Therapeutics Corporation | Compositions and methods for treatment of mitochondrial diseases |
US7807654B2 (en) | 1998-08-31 | 2010-10-05 | Wellstat Therapeutics Corporation | Compositions and methods for treatment of mitochondrial diseases |
US6472378B2 (en) * | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
CA2362925C (en) | 1999-02-23 | 2011-04-12 | Regents Of The University Of California | Methods of treatment of mitochondrial disorders |
WO2001068104A1 (en) * | 2000-03-16 | 2001-09-20 | The Mclean Hospital Corporation | Compounds for the treatment of psychiatric or substance abuse disorders |
US6727231B1 (en) | 2000-10-12 | 2004-04-27 | Repligen Corporation | Uridine therapy for patients with elevated purine levels |
AUPR951101A0 (en) | 2001-12-13 | 2002-01-24 | Centre For Molecular Biology And Medicine | Method of treatment |
CA2542023A1 (en) * | 2003-10-08 | 2005-09-22 | The Mclean Hospital Corporation | Methods of treating psychiatric, substance abuse, and other disorders using combinations containing omega-3 fatty acids |
CA2566612C (en) * | 2004-05-13 | 2015-06-30 | Massachusetts Institute Of Technology | Uridine effects on dopamine release |
EP2407167A3 (de) * | 2005-11-24 | 2012-06-27 | National University Corporation Hokkaido University | Therapeutikum für neurodegenerative Erkrankungen |
EP1897937A1 (de) * | 2006-09-07 | 2008-03-12 | NeuroProgen GmbH Leipzig | Verfahren zur Züchtung von neuralen Vorläuferzellen |
CN101896119A (zh) | 2007-11-02 | 2010-11-24 | 麻省理工学院 | 尿苷饮食添加顺应性方法及其用途 |
US20100041621A1 (en) * | 2008-08-15 | 2010-02-18 | Perry Renshaw | Methods and compositions for improving cognitive performance |
EP2459194A4 (de) | 2009-07-31 | 2012-12-19 | Clera Inc | Zusammensetzungen und verfahren zur behandlung von parkinson |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1178044B (it) * | 1984-10-09 | 1987-09-03 | Polifarma Spa | Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina |
JPH0669953B2 (ja) * | 1985-08-16 | 1994-09-07 | 日産化学工業株式会社 | 脳脊髄系神経栄養剤 |
CA1321994C (en) * | 1987-10-28 | 1993-09-07 | Reid Von Borstel | Acylated uridine and cytidine and uses thereof |
-
1988
- 1988-06-21 IT IT48118/88A patent/IT1219667B/it active
-
1989
- 1989-05-24 CA CA000600276A patent/CA1327003C/en not_active Expired - Fee Related
- 1989-06-13 JP JP1150354A patent/JPH0623109B2/ja not_active Expired - Fee Related
- 1989-06-14 EP EP89830264A patent/EP0348360B1/de not_active Expired - Lifetime
- 1989-06-14 AT AT89830264T patent/ATE100322T1/de not_active IP Right Cessation
- 1989-06-14 DE DE68912419T patent/DE68912419T2/de not_active Expired - Fee Related
- 1989-06-19 US US07/367,615 patent/US4960759A/en not_active Expired - Lifetime
- 1989-06-20 KR KR1019890008467A patent/KR900000092A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IT8848118A0 (it) | 1988-06-21 |
US4960759A (en) | 1990-10-02 |
JPH0245425A (ja) | 1990-02-15 |
EP0348360A2 (de) | 1989-12-27 |
EP0348360B1 (de) | 1994-01-19 |
IT1219667B (it) | 1990-05-24 |
EP0348360A3 (de) | 1991-10-23 |
ATE100322T1 (de) | 1994-02-15 |
CA1327003C (en) | 1994-02-15 |
KR900000092A (ko) | 1990-01-30 |
DE68912419T2 (de) | 1994-08-04 |
JPH0623109B2 (ja) | 1994-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68912419D1 (de) | Verwendung von Uridin zur Behandlung nervöser Störungen. | |
DK0431580T3 (da) | Substituerede cyclohexanoler med virkning på centralnervesystemet | |
DE69012591D1 (de) | Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen. | |
DE60216830D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen | |
DE60134453D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten | |
ES2078440T3 (es) | Compuestos farmaceuticos. | |
DE10199020I1 (de) | Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit | |
DE69017302D1 (de) | Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten. | |
DE69012261D1 (de) | Verwendung von Sertralin zur Behandlung verfrühter Ejakulation. | |
EP0616032A3 (de) | Verbeugende oder therapeutische Mittel für die Alzheimer-Krankheit, eine Siebtest-Methode, und die menschliche Tau-Protein-Kinase. | |
ES2086666T3 (es) | Composiciones de activacion cerebral. | |
DE69928521D1 (de) | Cabergolin und pramipexol zur behandlung von krankheiten des zentralnervensystems, insbesondere parkinsonscher krankheit | |
DE69822300D1 (de) | 3-pyridyl-1-azabicycloalkan-derivate zur behandlung von zns-erkrankungen | |
ATE147626T1 (de) | Verwendung von pirenzepine, telenzepine oder o- methoxy -sila-hexocyclium zur herstellung eines medikaments zur behandlung und regulierung der augenentwicklung | |
AU560542B2 (en) | Pyridazine derivatives which have c.n.s. activity | |
ATE96999T1 (de) | Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen. | |
DE3780542D1 (en) | Substituierte hexahydroarylchinolizine. | |
ATE80998T1 (de) | Verwendung von nalmefen zur herstellung eines arzneimittels zur behandlung der schaedigung des zentralnervensystems. | |
MX9206635A (es) | Cicloalquenos y cicloalcanos 1,3-substituidos como agentes del sistema nervioso central. | |
ATE78160T1 (de) | Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien. | |
MX9302225A (es) | Cicloalquenos y cicloalcanos 1,3-substituidos como agentes del sistema nervioso central. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |